"We recently discovered that beta-amyloid complexes in the blood can reflect amyloid load in the brain, and we developed technology that allows us to measure these protein complexes in the blood. Our work has shown that the determination of these complexes can identify people at the earliest stages of Alzheimer’s,” said Blaine Roberts, PhD, Associate Professor of Biochemistry at Emory University School of Medicine and co-Investigator.